Navigation Links
Colorcon Acquires Business of Pharmaceutical Coatings Pvt. Ltd. (India)
Date:7/26/2010

HARLEYSVILLE, Pa., July 26 /PRNewswire/ -- Colorcon, Inc. today announced the acquisition of the business of Pharmaceutical Coatings Pvt. Ltd. (India) which includes the company's full product portfolio, plus a new facility in Goa that is currently under construction.

The addition of the film coating products from this acquisition complement Colorcon's existing wide range of high-quality, one-step, tablet film coatings for pharmaceutical solid oral dose development.

Tabcoat TC®, one of the newly acquired products, is widely recognized in the Asia/Pacific market.  It is available as an organic, hydro-alcoholic, or aqueous solvent system which can be adjusted according to the needs of the customers, and the nature of the active ingredient in the formulation.  The addition of this product also augments Colorcon's offering for herbal / vitamin / nutraceutical formulation options for its regional customers.  

According to Jean-Claude Deneuville, President of Colorcon, Inc., "We are excited about this opportunity to expand our film coating offering.  The acquisition broadens and strengthens our ability to respond to the specific needs of companies in the fast growing Asia/Pacific region.  We will ensure the same high quality level of expertise, technical service, production and logistics support for these products that our customers have come to expect from Colorcon."  

About Colorcon

Colorcon is a world leader in the development, supply and support of formulated products for the pharmaceutical industry. Its core businesses include fi
'/>"/>

SOURCE Colorcon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
2. Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
7. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
8. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
9. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
11. Wound Management Technologies Acquires Resorbable Orthopedics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Ill. , July 1, 2015 ... nationwide group of state and regional professional rheumatology ... survey of rheumatologists that explored perceptions of biosimilars ... on patients. Biosimilars are medicines ... biologic medicines. They are notably different from generic ...
(Date:7/1/2015)... 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... corporate presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief ... a business and financial update on Wednesday, July 8, 2015 ... A live audio webcast of the presentation may be ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... 3 Glufosfamide and Phase 2 Glufosfamide Plus ... Gemcitabine Clinical Trials to be Presented, REDWOOD CITY, Calif., ... announced two presentations,regarding its oncology product candidate glufosfamide. The presentations,will ... held,September 23 to 27, 2007, at the International Conference Center ...
... First Hsp90 Inhibitor to Enter Registration Trials, HAYWARD, ... ) today announced that it has successfully,reached a binding ... the design of its TIME-1 clinical trial, a pivotal ... treatment for patients with,multiple myeloma. Through the FDA,s Special ...
Cached Medicine Technology:Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 2Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
(Date:7/1/2015)... ... 2015 , ... During the first week of June, Alamo ... Development) and Chuck Corso (Associate Sales Trainer) participated in the 44th Annual Life ... learning and development professionals from more than 300 life sciences companies around the ...
(Date:7/1/2015)... ... July 01, 2015 , ... As if mood swings, cramps and child ... number of women: leg pain. Northeast Houston Vein Center is offering tips on the ... venous reflux disease, is underdiagnosed and often overlooked. Many women experience the tiredness, achiness, ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... Transformation Task Force, contributing to newly released white paper: “Pro-actively Identifying the High-Cost ... was published July 1st and is available at: http://www.hcttf.org/resouces-tools . , The ...
(Date:7/1/2015)... ... 01, 2015 , ... Boar’s Head Brand®, one of the ... Independence Day celebrations with new takes on classic dishes. From chicken salad with ... any summertime get together. , “Celebrating with family, friends, and great food is ...
(Date:7/1/2015)... ... ... Camp wasn’t always a steadfast supporter of plastic surgery. But just as her career ... a terrible car accident years ago left her injured and in need of reconstructive ... What if I Do?): Answers to All Your Questions about Plastic Surgery” (published by Archway ...
Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2
... tilapia, one of the most highly consumed fish in ... acids and, perhaps worse, very high levels of omega-6 ... University School of Medicine. , The researchers say ... for some patients with heart disease, arthritis, asthma and ...
... in cases, experts say , , TUESDAY, July 8 (HealthDay News) ... pregnant does double or triple a woman,s risk, a new ... the sense that these are young women who are not ... Elkayam, a professor of medicine at the University of Southern ...
... Cardinal Health, a,global provider of products and ... care, today announced a consolidation of its,businesses into ... and align resources with the unique needs of ... and medical product,distribution centers and nuclear pharmacies will ...
... WASHINGTON, July 8 Michael E. Kerr, MD,Director of ... and a,psychiatrist in private practice, will address the topic ... has become one of the most widely,discussed and intensively ... reasons for a dramatic increase in the,number of children ...
... July 8 The Henry H. Kessler,Foundation, one ... announced today two key personnel changes that aim ... M.D., current President of Kessler,Medical Rehabilitation Research and ... DeLuca, Ph.D. will become the Vice President,for Research ...
... Health,s Document Management Solutions to Advance Efficiency and ... Statistics Office, CINCINNATI, July 8 Streamline ... that the Columbus Public,Health Vital Statistics Office will ... remote hosting services. As part of,their plan, the ...
Cached Medicine News:Health News:Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination 2Health News:Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination 3Health News:Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination 4Health News:Pregnancy Boosts Heart Attack Risk 2Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 2Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 3Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 4Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 5Health News:Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments 6Health News:The Henry H. Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary 2Health News:Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office 2Health News:Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office 3Health News:Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: